<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We evaluated the relation between dose and response for the neuroprotective effect of <z:chebi fb="3" ids="44915">propofol</z:chebi> in a rat model with incomplete <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>For clarification of the mechanism of neuroprotection, plasma <z:chebi fb="2" ids="33567">catecholamines</z:chebi> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha levels were measured </plain></SENT>
<SENT sid="2" pm="."><plain>Three doses (low, moderate and high-dose) of <z:chebi fb="3" ids="44915">propofol</z:chebi> were tested </plain></SENT>
<SENT sid="3" pm="."><plain>These produced, respectively, a low amplitude, slowing and a burst-suppression pattern of electroencephalographic activity </plain></SENT>
<SENT sid="4" pm="."><plain>Incomplete <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> was produced by right carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> combined with haemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo> (35 mmHg) for 30 min </plain></SENT>
<SENT sid="5" pm="."><plain>Neurological outcome at 72 h post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> in the high-dose group was significantly better than that in both low-dose and moderate-dose groups </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="3" ids="44915">Propofol</z:chebi> exhibited a trend in the dose-related attenuation of the increases in plasma <z:chebi fb="47" ids="28918,33568">adrenaline</z:chebi> and <z:chebi fb="15" ids="33569">noradrenaline</z:chebi> during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha increased during and after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> in <z:hpo ids='HP_0000001'>all</z:hpo> groups with no intergroup differences </plain></SENT>
<SENT sid="8" pm="."><plain>The results indicate that a burst-suppression dose of <z:chebi fb="3" ids="44915">propofol</z:chebi> provides neuroprotection </plain></SENT>
<SENT sid="9" pm="."><plain>The protective effect can not be completely explained by the attenuating effect on circulating <z:chebi fb="2" ids="33567">catecholamines</z:chebi> </plain></SENT>
</text></document>